Cargando…
Silenced ZNF154 Is Associated with Longer Survival in Resectable Pancreatic Cancer
Pancreatic cancer has become the third leading cause of cancer-related death in the Western world despite advances in therapy of other cancerous lesions. Late diagnosis due to a lack of symptoms during early disease allows metastatic spread of the tumor. Most patients are considered incurable becaus...
Autores principales: | Wiesmueller, Felix, Kopke, Josephin, Aust, Daniela, Roy, Janine, Dahl, Andreas, Pilarsky, Christian, Grützmann, Robert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862440/ https://www.ncbi.nlm.nih.gov/pubmed/31683647 http://dx.doi.org/10.3390/ijms20215437 |
Ejemplares similares
-
Evaluation of survival in patients after pancreatic head resection for ductal adenocarcinoma
por: Distler, Marius, et al.
Publicado: (2013) -
Targeted demethylation at ZNF154 promotor upregulates ZNF154 expression and inhibits the proliferation and migration of Esophageal Squamous Carcinoma cells
por: He, Wenting, et al.
Publicado: (2022) -
Precursor Lesions for Sporadic Pancreatic Cancer: PanIN, IPMN, and MCN
por: Distler, M., et al.
Publicado: (2014) -
Simultaneous gene silencing of Bcl-2, XIAP and Survivin re-sensitizes pancreatic cancer cells towards apoptosis
por: Rückert, Felix, et al.
Publicado: (2010) -
Simultaneous gene silencing of KRAS and anti-apoptotic genes as a multitarget therapy
por: Werner, Kristin, et al.
Publicado: (2015)